Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Incidence of Esophageal Adenocarcinoma and Causes of Mortality After Radiofrequency Ablation of Barrett's Esophagus.

Wolf WA, Pasricha S, Cotton C, Li N, Triadafilopoulos G, Muthusamy VR, Chmielewski GW, Corbett FS, Camara DS, Lightdale CJ, Wolfsen H, Chang KJ, Overholt BF, Pruitt RE, Ertan A, Komanduri S, Infantolino A, Rothstein RI, Shaheen NJ.

Gastroenterology. 2015 Dec;149(7):1752-1761.e1. doi: 10.1053/j.gastro.2015.08.048. Epub 2015 Aug 29.

2.

Sex and race and/or ethnicity differences in patients undergoing radiofrequency ablation for Barrett's esophagus: results from the U.S. RFA Registry.

Pasricha S, Li N, Bulsiewicz WJ, Rothstein RI, Infantolino A, Ertan A, Camara DS, Dellon ES, Triadafilopoulos G, Lightdale CJ, Madanick RD, Lyday WD, Muthusamy RV, Overholt BF, Shaheen NJ.

Gastrointest Endosc. 2015 Aug;82(2):276-84. doi: 10.1016/j.gie.2015.01.015. Epub 2015 Apr 1.

3.

Durability and predictors of successful radiofrequency ablation for Barrett's esophagus.

Pasricha S, Bulsiewicz WJ, Hathorn KE, Komanduri S, Muthusamy VR, Rothstein RI, Wolfsen HC, Lightdale CJ, Overholt BF, Camara DS, Dellon ES, Lyday WD, Ertan A, Chmielewski GW, Shaheen NJ.

Clin Gastroenterol Hepatol. 2014 Nov;12(11):1840-7.e1. doi: 10.1016/j.cgh.2014.04.034. Epub 2014 May 9.

4.

Prior fundoplication does not improve safety or efficacy outcomes of radiofrequency ablation: results from the U.S. RFA Registry.

Shaheen NJ, Kim HP, Bulsiewicz WJ, Lyday WD, Triadafilopoulos G, Wolfsen HC, Komanduri S, Chmielewski GW, Ertan A, Corbett FS, Camara DS, Rothstein RI, Overholt BF.

J Gastrointest Surg. 2013 Jan;17(1):21-8; discussion p.28-9. doi: 10.1007/s11605-012-2001-8. Epub 2012 Sep 11.

PMID:
22965650
5.

Incidence of symptomatic gallstones after gastric bypass: is prophylactic treatment really necessary?

Caruana JA, McCabe MN, Smith AD, Camara DS, Mercer MA, Gillespie JA.

Surg Obes Relat Dis. 2005 Nov-Dec;1(6):564-7; discussion 567-8.

PMID:
16925292
6.

Pharmacokinetics of methylprednisolone hemisuccinate and methylprednisolone in chronic liver disease.

Ludwig EA, Kong AN, Camara DS, Jusko WJ.

J Clin Pharmacol. 1993 Sep;33(9):805-10.

PMID:
8227476
7.

Pharmacokinetics and pharmacodynamics of methylprednisolone in obesity.

Dunn TE, Ludwig EA, Slaughter RL, Camara DS, Jusko WJ.

Clin Pharmacol Ther. 1991 May;49(5):536-49.

PMID:
1827621
8.

Update: gastroenterology and hepatology.

Camara DS, Corasanti JG.

Compr Ther. 1991 Apr;17(4):22-30. Review. No abstract available.

PMID:
1715250
9.

Peritoneovenous shunting as compared with medical treatment in patients with alcoholic cirrhosis and massive ascites. Veterans Administration Cooperative Study on Treatment of Alcoholic Cirrhosis with Ascites.

Stanley MM, Ochi S, Lee KK, Nemchausky BA, Greenlee HB, Allen JI, Allen MJ, Baum RA, Gadacz TR, Camara DS.

N Engl J Med. 1989 Dec 14;321(24):1632-8.

PMID:
2586565
10.

Response to W. Scott Brooks, Jr., on prophylactic sclerotherapy.

Camara DS.

Am J Gastroenterol. 1989 Mar;84(3):333-4. No abstract available.

PMID:
2919594
11.

Intestinal endotoxins as co-factors in liver injury.

Nolan JP, Camara DS.

Immunol Invest. 1989 Jan-May;18(1-4):325-37. Review.

PMID:
2659515
12.

Complications of gastrostomy.

Huff JP, Rosenblum J, Camara DS.

South Med J. 1988 Aug;81(8):1050-2. Review.

PMID:
3043685
13.

Intestinal endotoxins and macrophages as mediators of liver injury.

Nolan JP, Camara DS.

Trans Am Clin Climatol Assoc. 1989;100:115-25. Review. No abstract available.

14.

Severe ulceration and delayed perforation of the esophagus after endoscopic variceal sclerotherapy.

Bacon BR, Camara DS, Duffy MC.

Gastrointest Endosc. 1987 Aug;33(4):311-5. No abstract available.

PMID:
3498662
15.

Advances in the treatment of peptic ulcer disease.

Camara DS.

Compr Ther. 1987 Aug;13(8):13-6. No abstract available.

PMID:
2887333
16.

Bacteremia and injection sclerotherapy.

Camara DS.

Arch Intern Med. 1986 Mar;146(3):458-9. No abstract available.

PMID:
3954516
17.

IgA antibody to lipid A in alcoholic liver disease.

Nolan JP, DeLissio MG, Camara DS, Feind DM, Gagliardi NC.

Lancet. 1986 Jan 25;1(8474):176-9.

PMID:
2868205
18.

The hemodynamic effects of the sclerosant sodium morrhuate in dogs.

Camara DS, Caruana JA Jr, Chung RS, Amodeo DJ.

Surg Gynecol Obstet. 1985 Oct;161(4):327-31.

PMID:
4049201
19.

Heterotopic gastric mucosa: a case report.

Kundrotas LW, Camara DS, Meenaghan MA, Montes M, Wosick WF, Weiser MM.

Am J Gastroenterol. 1985 Apr;80(4):253-6.

PMID:
3984993
20.

Safety and pharmacokinetics of ceftazidime in patients with chronic hepatic dysfunction.

Pasko MT, Beam TR, Spooner JA, Camara DS.

J Antimicrob Chemother. 1985 Mar;15(3):365-74.

PMID:
3888944
21.

The importance of intestinal endotoxins in liver disease.

Nolan JP, Camara DS.

Prog Clin Biol Res. 1985;189:347-67.

PMID:
4048213
22.

Lack of effect of ceftazidime on serum glucose in patients with liver disease.

Beam TR Jr, Pasko MT, Spooner JA, Camara DS.

Clin Pharm. 1985 Jan-Feb;4(1):72-4. No abstract available.

PMID:
3882315
23.

The clearance capacity of the canine liver for a portal vein endotoxin infusion.

Caruana JA, Camara DS, Schneeberger GJ, Nolan JP.

J Surg Res. 1984 Sep;37(3):197-201.

PMID:
6379298
24.
25.

Streptococcus pneumoniae meningitis in two patients with peritoneovenous shunts.

Camara DS, Beam TR, Perakos PG, Caruana JA Jr.

Am J Gastroenterol. 1984 Apr;79(4):287-90.

PMID:
6711531
26.

Persistent bradyarrhythmia after sclerotherapy for esophageal varices.

Perakos PG, Cirbus JJ, Camara DS.

South Med J. 1984 Apr;77(4):531-2.

PMID:
6608794
27.

Rapid alterations in substrate profiles after partial hepatectomy in the rat.

Caruana JA, Sunby C, Camara DS, Chen HH, Schneeberger G.

Arch Surg. 1984 Apr;119(4):437-41.

PMID:
6367706
28.

Transient bacteremia following endoscopic injection sclerotherapy of esophageal varices.

Camara DS, Gruber M, Barde CJ, Montes M, Caruana JA Jr, Chung RS.

Arch Intern Med. 1983 Jul;143(7):1350-2.

PMID:
6870408
29.

D-Galactosamine liver injury: absorption of endotoxin and protective effect of small bowel and colon resection in rabbits.

Camara DS, Caruana JA Jr, Schwartz KA, Montes M, Nolan JP.

Proc Soc Exp Biol Med. 1983 Feb;172(2):255-9.

PMID:
6338507
30.

Diagnostic procedures in the evaluation of hepatic diseases. Functional evaluation. Other investigative indices: endotoxin.

Camara DS, Nolan JP.

Lab Res Methods Biol Med. 1983;7:195-8. Review. No abstract available.

PMID:
6353104
31.

Immunoradiometric assay of lipid A: a test for detecting and quantitating endotoxins of various origins.

Nolan JP, Vladutiu AO, Moreno DM, Cohen SA, Camara DS.

J Immunol Methods. 1982 Nov 26;55(1):63-72.

PMID:
6759581
32.

Functional and histopathologic changes in the liver during sepsis.

Caruana JA Jr, Montes M, Camara DS, Ummer A, Potmesil SH, Gage AA.

Surg Gynecol Obstet. 1982 May;154(5):653-6.

PMID:
6803371
33.

Endotoxin, sinusoidal cells, and liver injury.

Nolan JP, Camara DS.

Prog Liver Dis. 1982;7:361-76. Review. No abstract available.

PMID:
7051154
34.

Insulin, glucagon and glucose in the regeneration response of the liver.

Caruana JA Jr, Goldman JK, Camara DS, Gage AA.

Surg Gynecol Obstet. 1981 Nov;153(5):626-30.

PMID:
6270836
35.

Endoscopic retrograde cannulation of the esophagus (ERCE)

Salom IL, Woodman HM, Camara DS, Weiser M.

Gastrointest Endosc. 1981 Aug;27(3):198. No abstract available.

PMID:
7297836
36.

[Cellular and humoral immunity in active pulmonary tuberculosis. I. A study in patients reacting to 2 units of PPD].

Magarão MF, Oliveira-Lima A, Camara DS, Massuda HK, Ferreira GG.

Rev Inst Med Trop Sao Paulo. 1977 Jan-Feb;19(1):1-9. Portuguese. No abstract available.

PMID:
897472

Supplemental Content

Loading ...
Support Center